The Centre for Ethics and Public Policy (EPPC) published the results of an extended survey on complications from pharmacological abortion. The analysis covered more than 865,000 women's insurance claims, which experienced serious wellness complications after taking the abortion pill.
According to the EPPC report, as many as 10.93% of women reported adverse events or complications that doctors have identified as serious. This is as much as 22 times the percent of studies promoted by abortion and utilized by the U.S. Food and Drug Agency (FDA) in decisions to authorise and extend the usage of these measures.
Government Response
In the face of these data, Robert F. Kennedy Jr., wellness and Welfare Secretary (HHS), together with Dr. Marty Makary, FDA commissioner, announced a government verification of the safety and effectiveness of the usage of abortion pills. As underlined, the aim will be to examine the consequences of decisions taken at the Obama and Biden administration erstwhile many safeguards to defend women's wellness have been abolished.
Media storm and the interests of the abortion industry
As could be expected, the pro-abortion environments and their favorable media reacted with outrage. Critics of EPPC's investigation accused him of methodological errors and claimed that women's deaths after pharmacological abortion are highly uncommon and that serious complications affect little than 0.5% of cases.
However, the numbers presented by EPPC are irrefutable. Over 94,000 requests for compensation for complications are data that cannot be underestimated. Moreover, specified claims were recognised by insurance experts – institutions known for caution alternatively than for overzealousness in the payment of benefits. It means that these cases had a real medical burden.
True suffering – not statistics
Each of these cases is simply a circumstantial female who went to the ambulance due to bleeding, severe pain, infection, or anxiety. It is hard to talk of a "safe preparation" erstwhile tens of thousands of women are seeking aid in a state of wellness or life-threatening.
To underestimate these experiences is not only a technological error, but besides a deficiency of respect for the suffering of women. However, any pro-abortional environments, based on economical interests alternatively than patient care, strive to keep a communicative about the full safety of pharmacological abortion. Behind this communicative stands a powerful marketplace and with it – immense profits.
Independent studies confirm the risks
This is not the first time independent investigation centres have indicated a advanced proportion of complications. A 2009 Finnish survey of more than 42,000 patients showed that 20% of women experienced undesirable effects, including 15.6% of serious haemorrhages.
A Canadian survey of 2023 in Ontario Province, covering nearly 40,000 patients, showed that 10.3% of women were placed on rescue wards after taking abortion pills.
These results coincide with the EPPC analysis and are radically different from the data published by the abortion industry. This raises questions about the credibility of sources that have shaped public opinions and decisions of government institutions over the years.
Time to be honest with women
Facts are inexorable: pharmacological abortion is not a risk-free procedure. The FDA and another public wellness institutions are required to reliably measure the actual risks alternatively than replicate media slogans of safety "greater than with paracetamol".
Until a full independent study is produced based on actual medical practice data, it cannot be claimed that this measurement is safe. From the position of women's wellness concerns, even temporary withdrawal of abortion pills from the marketplace would be justified, at least until studies are completed and adequate safeguards are introduced.
jb
Source: Life News
